(D) Working model of LNA-miR-29 effects on plaque composition as detailed in the data of this paper. Administration of LNA-miR-29 blocks lesion growth and increases intra-plaque collagen expression and fibrous caps, two indices characteristic of more stable plaques. This panel was produced using Servier Medical Art (www.servier.com). 